Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Haematologica|March 1, 2002
Phase I trial with escalating doses of idarubicin and multidrug resistance reversal by short-course cyclosporin A, sequential high-dose cytosine arabinoside, and granulocyte colony-stimulating factor for adult patients with refractory acute leukemiaRenato Bassan, Teresa Lerede, Gianmaria Borleri, et al.
Leukemia & Lymphoma|July 16, 2005
Transplant-finalized salvage of adult acute lymphoblastic leukemia: results of a mitoxantrone- and methotrexate-based regimen in 36 patientsEros Di Bona, Enrico Pogliani, Giuseppe Rossi, et al.
Advances in Therapy|March 9, 2019
Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi StudyRenato Bassan, Dieter Hoelzer, Xavier Thomas, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|August 22, 2002
Prolonged administration of all-trans retinoic acid in combination with intensive chemotherapy and G-CSF for adult acute myelogenous leukemia: single-centre pilot study in different risk groupsRenato Bassan, Barbara Chiodini, Teresa Lerede, et al.
Haematologica|March 15, 2006
The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysisJosee Golay, Chiara Cortiana, Massimiliano Manganini, et al.
Cancers|June 13, 2020
Capture-based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular ProbesRoberta Cavagna, Marie L Guinea Montalvo, Manuela Tosi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 20, 2014
Prognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemiaOrietta Spinelli, Manuela Tosi, Barbara Peruta, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2017
Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic LeukemiaRenato Bassan, Tamara Intermesoli, Annamaria Scattolin, et al.
Leukemia & Lymphoma|August 1, 2023
Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a reviewFranco Locatelli, Bijal Shah, Tracy Thomas, et al.
Cancers|April 30, 2021
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALLManuela Tosi, Orietta Spinelli, Matteo Leoncin, et al.
Pageof 8